Haemodynamic Effects of Dobutamine and Nitrite in LV Dysfunction
NCT02888561 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2016-09-05
Summary
Patients with poor heart function can, in certain situations, have a further weakening of the heart muscle such that it becomes difficult to provide enough blood to the brain and other organs. In these cases, heart function can be supported by the use of medicines or heart pumps. One of the most widely used medicines is Dobutamine, given as an infusion (a drip). Although Dobutamine has been in use for decades and does improve blood flow to the organs, previous studies have not shown any impact on recovery of heart muscle function and survival. Key to unravelling this discrepancy is to understand the precise effects of Dobutamine on the oxygen supply to, and oxygen usage by, the heart muscle. We also aim to find out whether simultaneous infusion of another drug called Nitrite (naturally occurring substance that is found in beetroot for example, much like GTN) can enhance the beneficial effects of Dobutamine on the oxygen supply-demand balance of the heart. In recent years, major advances in technology mean that it is now possible to obtain this information in patients undergoing coronary angiography procedures by making detailed measurements of heart muscle function and blood flow in the heart arteries using a conductance catheter (measures volume and pressure within the main pumping chamber of the heart) and the Combowire (dual pressure and flow sensor tip angioplasty guidewire). The aim of this study is to understand the effect of a brief infusion of Dobutamine and nitrite on heart muscle function, oxygen supply and oxygen usage through this use of this technology, directly following the patients routine coronary angiogram. Patients will have these measurements taken using the technology described above during the infusion of both dobutamine and nitrite, inserted through blood vessels that reach the heart.
Conditions
Interventions
- DRUG
-
Dobutamine
Dobutamine will be infused at the time of coronary angiography while coronary and LV haemodynamics are measured using a Combowire (dual pressure and flow sensor tip guide wire) and left ventricular conductance catheter.
- DRUG
-
Nitrite
Nitrite will be infused at the time of coronary angiography while coronary and LV haemodynamics are measured using a Combowire (dual pressure and flow sensor tip guide wire) and left ventricular conductance catheter.
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure
NCT00270400 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
NCT02262078 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
NCT03016325 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure
NCT02767024 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers - Protocol 4
NCT01296607 ·Status: COMPLETED ·Phase: NA
-
Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure
NCT06158711 ·Status: NOT_YET_RECRUITING
-
Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.
NCT00348504 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy
NCT00842023 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
NCT00202579 ·Status: COMPLETED ·Phase: PHASE2
-
Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus Rhythm
NCT01266681 ·Status: UNKNOWN ·Phase: NA
-
Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction
NCT02918552 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Urocortins in Patients With Heart Failure
NCT01599728 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.
NCT00270374 ·Status: COMPLETED ·Phase: PHASE3
-
Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support
NCT05594342 ·Status: UNKNOWN ·Phase: PHASE3
-
The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
NCT04217135 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
NCT03189901 ·Status: UNKNOWN ·Phase: PHASE4
-
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
NCT06318260 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.
NCT00219388 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction
NCT01932606 ·Status: COMPLETED ·Phase: PHASE2
-
Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC
NCT00338455 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Dietary Nitrate Ingestion in Heart Failure
NCT03511248 ·Status: TERMINATED ·Phase: PHASE2
-
Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation
NCT01070667 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
NCT00288730 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy
NCT03380520 ·Status: COMPLETED ·Phase: PHASE4